Bombay Dyeing (Rs.122.00) (Code: 500020) :- The leading company from textile sector has also entered in to segment of real estate. The company owns lands at posh and prime locations of Mumbai like Worli and Dadar, the two suburbs of the city. Company has market capital of Rs. 443. crores. 52 weeks high and low price of the scrip is Rs. 1065 and Rs. 110. Business of real estate is prime business in Mumbai. After mitigation of effects of recessionary forces Realty market of Mumbai would be first to reap advantage of the change is likely to provide maximum benefit to the company. Rise in the crude price had adversely affected the company, but crude price has come down drastically during last 6 to 8 months. Investors are recommended to invest in the scrip at current market.
Zen Technologies (Rs. 89.00) (Code: 590032) :-The Hyderabad based company was established in 1993 and is active in the business of training stimulators designing, developing and manufacturing. Stimulators include driving and weaponry. During Q3 of current FY company has earned net profit of Rs. 4.73 crores on gross sale of Rs. 13.05 crores, which resulted in to EPS of Rs. 5.71 for the company. Company has current market capital of Rs. 71.94 crores. Company has order book of Rs. 64.29 crores on hand at the end of Q3 of current FY. Considering the planning of the company for new products and increase in manufacturing capacity and marketing investors may include the scrip in their portfolio.
NTPC (Rs.170.00) (Code: 532555) :-National Thermal Power Corporation, the biggest power producing company of the country was established in 1975. The company has also created a position at world level as a one of the biggest power producing company. It has bagged 41st rank amongst 2000 biggest company of the world. Company produces total 19.1 per cent of power from the gross production in the country. During FY 2007-08 its share was 28.50 per cent in gross production of power in country. Considering the huge base and capacity of the company GOI has termed the company as a one of the Navratna company of the country. Company has earned net profit of Rs. 7423 crores form gross sale of Rs. 37091 crores. During last quarter of the FY the company has earned net profit of Rs. 1726.5 crores from the gross sale of Rs. 9539.5 crores. Company has given 35 per cent dividend to its share holders. Invest on the counter at current market price with target price of Rs. 198 to 200.
Opto Circuit (Rs.79.00) (Code: 532391) :- Net profit of the company has increased by 77 per cent and sales by 51 per cent during last three years. During last 9 months period ended in December, 2008 company has successfully maintained the momentum. During same 9 month period sales of the company improved by 74 per cent to Rs. 605 crores and net profit by 58 per cent to Rs. 154 crores. Company had declared bonus at the ratio of 7:10 in May 2008 Considering the rising demand in healthcare segment financial performance of the company is expected to improve during coming months. Grab the opportunity to invest at current market price for medium to long term.
Glen mark Pharma (Rs.129.00) (Code: 532296) :- Company is one of the fast developing Indian formulation company. Company has diversified its business in to new geographic and API segments, which has resulted in to huge rise in the income of the company. During Q3 of current FY company has earned net profit of Rs. 36.92 crores from gross business of Rs. 244.55 crores, which has resulted in to EPS of Rs. 1.47. Volume has increased on the counter at current price. Stock price has bounced back after creating a strong bottom at Rs. 120. There are indications of fresh buying on the counter. Invest on the counter for medium to long term. Include the stock in your portfolio.
Opto Circuit (Rs.79.00) (Code: 532391) :- Net profit of the company has increased by 77 per cent and sales by 51 per cent during last three years. During last 9 months period ended in December, 2008 company has successfully maintained the momentum. During same 9 month period sales of the company improved by 74 per cent to Rs. 605 crores and net profit by 58 per cent to Rs. 154 crores. Company had declared bonus at the ratio of 7:10 in May 2008 Considering the rising demand in healthcare segment financial performance of the company is expected to improve during coming months. Grab the opportunity to invest at current market price for medium to long term.
Glen mark Pharma (Rs.129.00) (Code: 532296) :- Company is one of the fast developing Indian formulation company. Company has diversified its business in to new geographic and API segments, which has resulted in to huge rise in the income of the company. During Q3 of current FY company has earned net profit of Rs. 36.92 crores from gross business of Rs. 244.55 crores, which has resulted in to EPS of Rs. 1.47. Volume has increased on the counter at current price. Stock price has bounced back after creating a strong bottom at Rs. 120. There are indications of fresh buying on the counter. Invest on the counter for medium to long term. Include the stock in your portfolio.
Source: Internet (SmartInvestment)
